Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Accounts-Payable" stands at 168.65 Billion Japanese Yens as of 09/30/2025.
As of the end of Astellas Pharma Inc.'s second quarter, the item "Accounts Payable" stands at 168.65 Billion JPY. This represents an increase of 1.67 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 4.65 percent compared to the value the year prior.
The 1 year change in percent is 4.65.
The 3 year change in percent is 15.10.
The 5 year change in percent is 48.58.
The 10 year change in percent is -16.52.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Accounts Payable | 905,699,262,464.00 |
![]() | Johnson & Johnson - Accounts Payable | 486,508,953,600.00 |
![]() | AbbVie Inc - Accounts Payable | 399,570,305,024.00 |
![]() | Roche Holding AG - Accounts Payable | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Accounts Payable | 280,205,508,085.11 |